Astrana Health (NASDAQ:ASTH) Price Target Raised to $59.00 at Truist Financial

Astrana Health (NASDAQ:ASTHFree Report) had its target price increased by Truist Financial from $50.00 to $59.00 in a research report sent to investors on Friday, Benzinga reports. They currently have a buy rating on the stock.

Several other equities analysts have also recently issued reports on the company. Stifel Nicolaus lifted their price target on Astrana Health from $48.00 to $60.00 and gave the company a buy rating in a research report on Thursday, August 1st. Baird R W upgraded Astrana Health to a strong-buy rating in a research report on Thursday, May 30th. Finally, Robert W. Baird started coverage on Astrana Health in a report on Thursday, May 30th. They issued an outperform rating and a $54.00 target price on the stock. Four analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of Buy and an average price target of $55.75.

Check Out Our Latest Stock Analysis on ASTH

Astrana Health Price Performance

Shares of Astrana Health stock opened at $46.74 on Friday. Astrana Health has a 1-year low of $28.86 and a 1-year high of $54.27. The company has a market cap of $2.62 billion, a P/E ratio of 35.41, a P/E/G ratio of 1.83 and a beta of 1.16. The firm’s fifty day simple moving average is $44.45. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.56.

Astrana Health (NASDAQ:ASTHGet Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.01. Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. The company had revenue of $486.30 million for the quarter, compared to analysts’ expectations of $440.68 million. During the same period last year, the firm earned $0.28 EPS. The firm’s revenue for the quarter was up 39.7% on a year-over-year basis. On average, research analysts expect that Astrana Health will post 1.42 earnings per share for the current fiscal year.

About Astrana Health

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Further Reading

Analyst Recommendations for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.